Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

50

Revenue 2017

Levemir

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Levemir was produced by Novo Nordisk.

Novo Nordisk preps for speedy oral GLP-1 drug filing

Novo Nordisk preps for speedy oral GLP-1 drug filing

products. Long-acting insulin sales shrank 6% to 20.8bn krone overall, mainly due to a sharp decline in top-seller Levemir (insulin detemir) which fell 21%, although there was a

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Xultophy’s performance helped prop up the insulin category as it copes with a slide in sales of top seller Levemir (insulin detemir), which shrank by almost a quarter to

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and

Lilly and Boehringer launch first Lantus clone Basaglar in US

Lilly and Boehringer launch first Lantus clone Basaglar in US Nordisk's Levemir (insulin detemir) and Tresiba (insulin degludec). ... The list price of Basaglar in the US is $316.85 for a pack of five autoinjector pens, which also undercuts Sanofi's Lantus follow-up Toujeo, as well as Levemir

Sanofi fires off another lawsuit against a Lantus biosimilar

Sanofi fires off another lawsuit against a Lantus biosimilar Lantus made more than $7bn in sales last year but is already showing the effects of competition from biosimilars and other branded basal insulin rivals such as Novo Nordisk's Levemir

1 2 3 4 5 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics